SEC Form 8-K Summary
Registrant: Brilliant Acquisition Corporation, although the request identifies T3 Defense Inc. The filing is dated December 19, 2022, and reports events occurring on that date. Brilliant is a special purpose acquisition company pursuing a proposed business combination with Nukkleus, Inc.
Business Context and Reporting Period
The proposed transaction would involve Merger Sub, Inc. merging into Brilliant, with Brilliant becoming a wholly owned subsidiary of Nukkleus. The filing primarily concerns financing for an extension of Brilliant’s deadline to complete its initial business combination.
Key Financial and Capital Structure Items
- Brilliant issued Nukkleus an unsecured, non-interest-bearing promissory note with a principal amount of $22,600.
- The note matures upon completion of Brilliant’s initial business combination.
- If no business combination is completed, repayment is limited to amounts remaining outside Brilliant’s trust account, if any.
- Note proceeds were deposited into Brilliant’s trust account in connection with extending the business-combination completion period.
- The filing does not provide revenue, profit, cash-flow, margin, total debt, or liquidity metrics beyond the note terms.
Material Changes and Outlook
- Brilliant extended its business-combination deadline by one month, to January 23, 2023.
- The proposed Nukkleus transaction remained subject to stockholder approvals, minimum trust-account requirements after redemptions, regulatory approvals, and other closing conditions.
- The filing does not provide operating guidance or financial forecasts for Brilliant or Nukkleus.
Risks, Contingencies, and Unusual Items
- The business combination might not close on time or at all, including if required approvals or other conditions are not satisfied.
- Failure to complete a transaction by the deadline could result in liquidation-related consequences and repayment of the note only from funds outside the trust account, if any.
- Potential risks include shareholder redemptions, insufficient trust-account funds, regulatory issues, litigation, Nasdaq listing risks, transaction-related disruption, and volatility in the securities of Brilliant and Nukkleus.
- The company furnished a press release under Regulation FD; the filing states that this information is not deemed filed for purposes of Section 18 of the Exchange Act.
Important Facts for Investors to Verify
- Confirm that the filing relates to Brilliant Acquisition Corporation rather than T3 Defense Inc.
- Review the full December 19, 2022 promissory note filed as Exhibit 10.1.
- Verify whether the proposed Nukkleus business combination ultimately closed and whether additional extensions were obtained.
- Review the applicable proxy statement/prospectus and SEC filings for redemption levels, trust-account balances, closing conditions, and liquidation provisions.
- Assess the effect of the $22,600 note and its limited repayment source if no business combination occurs.